July 6, 2011 Warriors Name Marty Glick Chief Financial Officer Former VP of Finance For Genentech Has Excelled In Biotech Field
The Golden State Warriors have named Marty Glick as the team’s Chief Financial Officer (CFO), it was announced today. Glick, who is also a minority owner of the club, will begin his new duties immediately. He will oversee all day-to-day and long-term financial planning and accounting for the organization, while reporting directly to Co-Owner Joe Lacob.
Glick, a highly-regarded former biotech executive whose affiliations have a history of innovative success, has accumulated a wealth of experience as a prominent financial figure for several large biotech businesses, including Genentech of South San Francisco, where he spent over a decade (1987-1997), most recently as Vice President of Finance. He also served as Executive Vice President and Chief Financial Officer of Theravance, a Bay Area-based drug discovery company, for seven years (1998-2005) and was a Co-Founder and Board Member of Eyetech Pharmaceuticals. Additionally, Glick was Co-Founder and Chairman of the Board of PEAK Surgical – an innovative private medical device company – and his resume also includes a seven-plus year stint as the Chair of the Biotech Tax and Finance Committee.
“I’m really pleased to have someone the caliber of Marty Glick on board as our new CFO,” said Lacob. “His experience and expertise will be a tremendous asset and will prove invaluable as we move forward in our quest to build a World Class organization from top to bottom.”
A native of Chicago, Illinois, Glick earned his MBA in Finance at Kellogg School of Management (Northwestern University) and his BSBA in Accounting at Creighton University.
You do not have the correct version of the Flash Player Plugin. Click here to get it.
NBA Media Ventures, LLC | Turner Sports Interactive, Inc.All rights reserved. No portion of NBA.com may be duplicated, redistributed or